These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment. Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615 [TBL] [Abstract][Full Text] [Related]
23. Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin? Henry TD; Satran D; Knox LL; Iacarella CL; Laxson DD; Antman EM Am Heart J; 2001 Oct; 142(4):590-3. PubMed ID: 11579347 [TBL] [Abstract][Full Text] [Related]
24. [Antiphospholipid antibody syndrome: a priori a contraindication to kidney transplantation?]. Rubenwolf P; Lopau K; Gerharz EW; Heidbreder E; Riedmiller H Aktuelle Urol; 2007 Mar; 38(2):132-6. PubMed ID: 17390275 [TBL] [Abstract][Full Text] [Related]
25. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively. Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258 [TBL] [Abstract][Full Text] [Related]
26. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?]. Ruiz Manzano J; Monreal M Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434 [No Abstract] [Full Text] [Related]
27. Bridging of oral anticoagulation therapy for invasive procedures. Spyropoulos AC Curr Hematol Rep; 2005 Sep; 4(5):405-13. PubMed ID: 16131443 [TBL] [Abstract][Full Text] [Related]
28. Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina. Klootwijk P; Lenderink T; Meij S; Boersma H; Melkert R; Umans VA; Stibbe J; Müller EJ; Poortermans KJ; Deckers JW; Simoons ML Eur Heart J; 1999 Aug; 20(15):1101-11. PubMed ID: 10413640 [TBL] [Abstract][Full Text] [Related]
29. Low-molecular-weight heparin in outpatient treatment of DVT. Yeager BF; Matheny SC Am Fam Physician; 1999 Feb; 59(4):945-52. PubMed ID: 10068716 [TBL] [Abstract][Full Text] [Related]
30. Another perspective on monitoring anticoagulation therapy. Burnakis TG Ann Pharmacother; 1995 Oct; 29(10):1045-6. PubMed ID: 8845545 [No Abstract] [Full Text] [Related]
31. Nomograms for the administration of unfractionated heparin. Grubb H; Lovett J; Kingman HM; Copplestone JA; Prentice AG Thromb Haemost; 2001 Mar; 85(3):565. PubMed ID: 11307835 [No Abstract] [Full Text] [Related]
33. Effect of a sliding scale protocol for heparin on the ability to maintain whole blood activated partial thromboplastin times within a desired range in hemodialysis patients. Low CL; Bailie G; Morgan S; Eisele G Clin Nephrol; 1996 Feb; 45(2):120-4. PubMed ID: 8846524 [TBL] [Abstract][Full Text] [Related]
34. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives]. Prandoni P; Simioni P; Pagnan A Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718 [TBL] [Abstract][Full Text] [Related]